NCT07002034 2026-04-22RE104 Safety and Efficacy Study in Adjustment Disorder in Cancer and Other Medical IllnessesReunion Neuroscience IncPhase 2 Recruiting100 enrolled
NCT03816345 2026-04-21Testing an Immunotherapy Anti-cancer Drug, Nivolumab, for Advanced Cancers in Patients With Autoimmune Disorders, AIM-NIVONational Cancer Institute (NCI)Phase 1 Recruiting300 enrolled
NCT07304154 2026-04-21A Study Evaluating the Safety and Efficacy of KITE-363 in Relapsed/Refractory Autoimmune Neurologic DiseasesGilead SciencesPhase 1 Recruiting52 enrolled
NCT07526493 2026-04-13Safety and Pharmacodynamics of QH103 Cell Injection in the Treatment of Patients With Relapsed/Refractory Antibody-Mediated Neurological Autoimmune Diseases.Tongji HospitalPhase 1 Recruiting6 enrolled
NCT06680037 2026-04-07A Study to Assess the Safety and Clinical Activity of Azer-cel in Participants With B-cell Mediated Autoimmune DisordersTG Therapeutics, Inc.Phase 1 Recruiting32 enrolled
NCT05819008 2026-04-01Remote Neuropsychological Assessment of Patients With Neurological Disorders and InjuriesUmeå UniversityRecruiting350 enrolled